- Aleafia Health Inc. (AH) has closed its bought deal offering
- 27,390,000 units were issued at a price per unit of $0.83 for gross proceeds of $22.7 million
- The offering was led by Cantor Fitzgerald Canada Corporation, as lead underwriter and sole bookrunner
- Underwriters included Echelon Wealth Partners Inc. and Mackie Research Capital Corp.
- Proceeds will be used to fund growth opportunities and working capital initiatives
- Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services
- Aleafia Health Inc. (AH) is up 6.06 per cent, trading at C$0.70 per share at 1:45 pm EST
Aleafia Health Inc. (AH) has closed its bought deal offering.
A total of 27,390,000 units were issued at a price per unit of $0.83 for gross proceeds of $22.7 million, including a partial exercise of the over-allotment option.
The offering was led by Cantor Fitzgerald Canada Corporation, as lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters including Echelon Wealth Partners Inc. and Mackie Research Capital Corp.
Each unit consists of one common share and one-half of one common share purchase warrant.
Each warrant entitles the holder to purchase one common share at an exercise price of $1.05, for a period of 24 months following the closing of the offering.
Net proceeds will be used to fund growth opportunities and working capital initiatives.
Warrants issued in connection with the offering will commence trading on the Toronto Stock Exchange under the symbol “AH.WT.B”.
The offering is subject to final acceptance from the TSX.
Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and in international markets. Aleafia operates medical clinics, education centres and production facilities for the production and sale of cannabis.
Aleafia Health Inc. (AH) is up 6.06 per cent, trading at C$0.70 per share at 1:45 pm EST.
